[1]
N. T. Dobrovolskienė, “Expression of tolerogenic potential-representing markers on clinical-grade therapeutic dendritic cell-based cancer vaccines”, AML, vol. 20, no. 4, pp. 161–173, Feb. 2014, doi: 10.6001/actamedica.v20i4.2813.